| 项目编号 |
PRJCA011026 |
| 项目标题 |
Primary liver cancer treated with lenvatinib plus PD-1 |
| 涉及领域 |
Medical |
| 数据类型 |
Single cell sequencing
|
| 物种名称 |
Homo
|
| 描述信息 |
Revaeling the tumor microenvironment of primary liver cancer after treatment of lenvatinib plus PD-1 antibodies. |
| 样品范围 |
Single cell |
| 发布日期 |
2022-08-23 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 40856889
|
PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma
|
Discover Oncology
|
10.1007/s12672-025-03481-4
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China (NSFC)
|
Key Program
|
82072677
|
|
| National Natural Science Foundation of China (NSFC)
|
Young Scientists Fund
|
82072672
|
|
|
|
| 提交者 |
shuang-jian
Qiu (qiu.shuangjian@zs-hospital.sh.cn)
|
| 提交单位 |
Zhongshan Hospital, Fudan University |
| 提交日期 |
2022-08-05 |
